News

Solar Group Maintains DKK 600M EBITDA Guidance for 2024

Solar Group Maintains DKK 600M EBITDA Guidance for 2024

Solar Group Reconfirms EBITDA Guidance Amid Market Adjustments

Solar Group has revealed that its EBITDA expectations remain unchanged at DKK 600 million for the year, despite facing a more sluggish market recovery than initially predicted. While the company maintains its EBITDA forecast, it has revised its revenue guidance downward from DKK 12,500 million to DKK 12,300 million. This adjustment reflects the challenges the market poses on growth and operational performance.

Insights from CEO Jens Andersen

As per the statement from CEO Jens Andersen, the company experienced a slight organic growth adjustment of -0.6% in September. This percentage indicates that while recovery is taking shape, particularly in Denmark, the overall pace is slower than anticipated. "We are witnessing gradual improvements across various markets, but the recovery is taking longer than we'd hoped," says Andersen.

Encouraging Trends in Industrial Heat Pumps

Despite these challenges, the sector for industrial high-capacity heat pumps is reporting an uptick in conversion rates, which has resulted in an increase in orders. This positive trend is encouraging, signaling that the underlying demand may be stronger than reflected in broader market conditions.

Financial Highlights and Q3 Performance

The third quarter (Q3) financial results were in line with projections, showcasing continuous quarter-on-quarter improvements in EBITDA. The confirmation of EBITDA guidance for 2024 at DKK 600 million reinforces confidence in the company's strategic approach, even amid fluctuating market dynamics.

Looking at Q3 Financial Results

To give a clearer picture of the financial context, here are key figures for Q3 2024 compared to Q3 2023:

  • Revenue: DKK 2,860 million, down from DKK 2,965 million.
  • EBITDA: DKK 202 million, compared to last year’s DKK 187 million.
  • Cash flow from operating activities displayed a concerning -DKK 196 million, a significant decline from DKK 190 million in Q3 2023.
  • Organic growth, adjusted for working days, dropped to -5.3% from -4.7% the previous year.
  • EBITDA margin improved to 7.1%, up from 6.3%.

Guidance and Future Outlook

Solar Group`s revised revenue guidance takes into account the unpredictable nature of the current market influenced by macroeconomic uncertainties. While the company's outlook remains cautious, there's hope for an economic rebound towards year-end 2024, albeit at a slower pace.

Company’s Core Objectives

The group is committed to improving operational efficiency and is focused on leveraging digital tools that can enhance customer competitiveness while promoting sustainable practices. Solar Group emphasizes its role in driving the green transition, working towards the sustainable utilization of resources.

Investor Engagement and Communication

The company plans to present its Q3 2024 report in an audio webcast scheduled for later this month. Participants will receive instructions on how to join the teleconference, with encouragement for questions from stakeholders to foster engagement during the presentation.

Key Contacts for Inquiries

For further inquiries, stakeholders can contact:

  • CEO Jens Andersen at +45 79 30 02 01
  • CFO Michael H. Jeppesen at +45 79 30 02 62
  • IR Director Dennis Callesen at +45 29 92 18 11

About Solar Group

With a solid reputation as a top-tier European sourcing and services company, Solar specializes in electrical, heating, plumbing, ventilation, and energy solutions. The dedication to optimizing customer engagement through innovative solutions and service excellence sets Solar apart in the competitive landscape. The company achieved revenues of approximately DKK 13.0 billion, employing around 3,000 professionals within its operations.

Frequently Asked Questions

What is Solar Group's EBITDA guidance for 2024?

Solar Group has reaffirmed its EBITDA guidance at DKK 600 million for 2024.

How has revenue guidance changed?

The revenue guidance has been revised downwards from DKK 12,500 million to DKK 12,300 million due to market conditions.

Who is the CEO of Solar Group?

The CEO of Solar Group is Jens Andersen.

Which sector is showing improved order conversions?

The industrial high-capacity heat pumps sector is experiencing increased order conversions.

How can stakeholders engage in the upcoming report presentation?

Stakeholders can join the presentation via an audio webcast and are encouraged to ask questions during the teleconference.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 132

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 247

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 153

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Aalberts Shares Buyback Program Updates and Insights

Updated Category News Views 113

Overview of Aalberts' Share Buyback Program Aalberts has recently announced the progress of its ongoing share buyback program, giving investors and shareholders a detailed look into its current operations. This program is part of a strategic initiative to enhance shareholder value and demonstrate confidence in the company's long-term prospects. Recent Share Repurchase...

Continue Reading
American Water Named Among 2025 Most Responsible Companies

Updated Category News Views 206

American Water's Recognition on Newsweek’s List American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., is proud to announce its inclusion in Newsweek’s list of America’s Most Responsible Companies for 2025. This honor reflects American Water's unwavering commitment to environmental, social, and governance (ESG)...

Continue Reading
Pendulum Ink Reimagines Hip-Hop Education with New Model

Updated Category News Views 289

Pendulum Ink Innovates Online Hip-Hop Education Pendulum Ink, recognized as the world's first online hip-hop academy, has made headlines with its recent relaunch featuring a subscription-based model. This new structure is designed to provide flexible engagement tiers, making hip-hop education accessible to learners around the globe. The relaunch not only aims to educate...

Continue Reading
Revolutionizing Radiology: Mach7 Technologies Launches UnityVue

Updated Category News Views 90

Mach7 Technologies Introduces UnityVue for Radiology Mach7 Technologies is thrilled to announce the release of UnityVue, an advanced, AI-driven workflow orchestration solution designed to enhance patient care, alleviate radiologist burnout, and optimize diagnostic workflows. This innovative platform aims to create a more efficient radiology environment, making it a...

Continue Reading
Purina Partners with UC Davis to Enhance Pet Urinary Health

Updated Category News Views 150

Purina Teams Up with UC Davis School of Veterinary Medicine Nestlé Purina PetCare is thrilled to share a groundbreaking partnership with the University of California, Davis. This collaboration is focused on improving our understanding of urinary health in pets. With the support of a generous grant, this initiative represents a major step forward in scientific research...

Continue Reading